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We have previously shown that the replication of avian reovirus (ARV) in chicken embryo ﬁbroblasts
(CEF) is more resistant to the antiviral action of interferon (IFN) than the replication of vesicular sto-
matitis virus (VSV) or vaccinia virus (VV). In this study we examined the capacity of these three viruses to
induce the expression of IFN when infecting avian cells. Efﬁcient expression of both type-α and type-β
IFNs, as well as of the double-stranded RNA (dsRNA)-activated protein kinase (PKR), takes place in ARV-
infected CEF, but not in cells infected with VSV or VV. PKR expression is not directly induced by ARV
infection, but by the IFN secreted by ARV-infected cells. IFN induction in ARV-infected cells requires viral
uncoating, but not viral gene expression, a situation similar to that reported for apoptosis induction by
ARV-infected cells. However, our results demonstrate that IFN induction by ARV-infected CEF occurs by a
caspase-independent mechanism.
& 2015 Elsevier Inc. All rights reserved.Introduction
Interferons (IFNs) comprise a family of multifunctional cyto-
kines that were originally discovered by their strong antiviral
activity (Isaacs and Lindenmann, 1957), and which are now
recognized as the ﬁrst barrier that viruses have to overcome to
establish a productive infection. Of the three IFN types, type I
interferon-α/β displays the highest antiviral activity and its
expression is induced in many cell types by viral infection or fol-
lowing contact with double-stranded RNA (dsRNA) (reviewed in
Samuel (2001)).
Successful host defense against viruses relies on early detection
of intracellular virus particles followed by the rapid production of
type I interferons. For this, cells contain a series of endosomal and
cytosolic sensors, called pattern recognition receptors (PRRs),
which recognize pathogen associated molecular patterns (PAMPs),
such as viral nucleic acids or viral intermediate products. When
contacting PAMPs, PRRs become activated and transmit intracel-
lular signaling pathways, culminating in the activation of speciﬁc
transcription factors that translocate to the nucleus to stimulate
type I IFN promoters (reviewed in Diebold (2010), Edwards et al.
(2007), Jefferies and Fitzgerald (2005), Koyama et al. (2008) and
Yoneyama and Fujita (2010)). Newly-synthesized type I IFNs areuímica Biológica y Materiales
de Santiago de Compostela,
15704.
(J. Benavente).secreted out of the cell to interact with the ubiquitously expressed
IFNAR receptor complex present in neighboring cells. This inter-
action triggers the activation of a signal transduction pathway that
leads to increased expression of the designated IFN-stimulated
genes (ISGs), thus creating an antiviral state. Subsequent viral
infection of IFN-primed cells induces the activation of ISG-encoded
proteins; the antiviral activity of these proteins prevents further
dissemination of the virus (reviewed in Doly et al. (1998), Haller
et al. (2006), Sadler and Williams (2008), Samuel (2001) and
Takaoka and Yanai (2006)).
Despite that IFN was initially discovered as a soluble chicken
factor that directly interfered with inﬂuenza virus replication in
chorioallontoic membranes of chicken embryos (Isaacs and Lin-
denmann, 1957), our understanding of the host response to
pathogens in poultry is very limited, since most efforts were
dedicated at characterizing the antiviral response in mammals.
However, interest in IFNs of birds has recently emerged from
increasing problems with viral diseases in poultry and from the
observation that chickens infected with highly pathogenic avian
inﬂuenza virus strains pose a high threat to human health (Imai et
al., 2013; Karpala et al., 2012; Poovorawan et al., 2013). As in
mammals, three types of chicken IFN (chIFN) have been identiﬁed
in virus-infected chicken cells, and all three have been reported to
display antiviral activity (reviewed in Goosens et al. (2013)). Type I
chIFN, which comprises multiple chIFN-α isoforms and a single
chIFN-β, has the strongest antiviral activity, although chIFN-α is
the dominant virus-induced IFN subtype produced by virus-
infected avian cells (Schultz et al., 1995; Schwarz et al., 2004), a
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This, and the observations that chIFN-α exhibits stronger antiviral
activity than chIFN-β against several viruses and greater induction
potency on several ISGs encoding antiviral proteins (Qu et al.,
2013; Schwarz et al., 2004), suggests that chIFN-α is the main
defense used by chicken cells to combat viral infections.
Previous studies from different laboratories, including ours, have
revealed that the replication of avian reovirus (ARV) in cultured avian
cells is much more resistant to the antiviral action of chIFN than
vaccinia virus (VV), vesicular stomatitis virus (VSV) or Semliki Forest
virus (Ellis et al., 1983; González-López et al., 2003; Martinez-Costas
et al., 2000; Sekellick et al., 1994). In this study we have examined the
capacity of ARV, VV and VSV to induce IFN expression when infecting
avian cells. We found that IFN is only expressed and secreted by ARV-
infected cells and that IFN induction requires virus uncoating, but not
the expression of the ARV genes.Results
IFN induction by virus-infected avian cells
In the ﬁrst part of this study we sought to compare the capacity
of ARV, VV and VSV to induce the production and secretion of IFN
by infected avian cells. Our previous ﬁnding that VSV and VV are
very sensitive to priming of CEF cells with IFN (Martinez-Costas et
al., 2000) suggests that IFN should not be secreted by avian cells
infected with these two viruses, otherwise the IFN present in the
viral stocks used to infect the cells would block viral replication. In
the case of VV, this suggestion is supported by the results of
previous studies that revealed that chIFN activity was not detected
upon infection of CEF cells with wild-type VV (Hornemann et al.,
2003). In contrast, it has been recently reported that infection of
the CEF-derived avian cell line DF1 with VSV induces increasing
expression of the mRNAs coding for chIFN-α and chIFN-β (Qu et
al., 2013), although the presence of IFN in the cultured medium of
VSV-infected cells was not examined in this study.Fig. 1. IFN induction by virus-infected CEF cells. (A) CEF monolayers were mock-infecte
were lysed and the resulting extracts were analyzed by Western blot with anti-chPKR (to
the same cells shown in A were added to the culture medium of CEF cell monolayers a
compared by Western blotting. A Western blot analysis of extracts from uninfected CEF
and B. (C) Virus-free supernatants from the same cells shown in A were added to the
plasmid. These cells, as well as IFN-primed uninfected cells, were lysed 24 h later and
induction of the Mx promoter-dependent ﬁreﬂy luciferase was expressed as fold induc
independent experiments. The error bars indicate the standard deviation of three measTo determine the capacity of the three viruses to induce chIFN
expression, we ﬁrst analyzed by Western blot the intracellular
levels of the IFN-inducible protein PKR in virus-infected CEF cells.
Since the possibility existed that IFN is produced and secreted by
ARV-infected CEF, and consequently that the ARV stock used to
infect the cells contains chIFN, the infection with ARV was carried
out with a suspension of puriﬁed reovirions devoid of cellular
proteins (Grande and Benavente, 2000). VSV and VV viruses did
not require puriﬁcation since these viruses were grown on BHK-21
hamster cells and therefore their stocks should not contain chIFN.
The results shown in Fig. 1A revealed that PKR expression was
induced when the cells were infected with ARV, but not when
infected with VSV or VV, suggesting that IFN is only expressed by
ARV-infected cells. To conﬁrm this suggestion, we analyzed the
presence of IFN in the cultured medium (supernatant) of virus-
infected CEF cells by two different approaches. In the ﬁrst
approach, we examined the capacity of virus-free supernatants to
induce PKR expression when incubated with monolayers of
uninfected CEF. Viral particles were removed from the super-
natants of infected cells by precipitation with perchloric acid at
4 °C, as previously reported (Sekellick and Marcus, 1986), but
similar results were obtained when the viral particles were inac-
tivated by incubating the supernatants at 65 °C for 30 min (Liniger
et al., 2012). The results shown in Fig. 1B revealed that only the
supernatant from ARV-infected cells, but not those from cells
infected with VSV or VV, was able to induce the expression of PKR.
In the second approach, we determined the capacity of the
supernatants to activate the promoter of the chicken Mx gene
contained within the reporter pGL3-P-chMx-luc plasmid (Liniger
et al., 2012). The supernatants were incubated with plasmid-
transfected DF1 cells, since control experiments revealed that
the transfection of any plasmid into CEF cells, but not into DF1
cells, already induces PKR expression (not shown). The results
shown in Fig. 1C revealed that only the supernatant from ARV-
infected CEF was able to activate the Mx promoter. Taken together,
these results demonstrate that infection of CEF with ARV, but not
with VSV or VV, induces the production and secretion of chIFN.d (U) or infected with 2 PFU/cell of the viruses indicated on top. At 18 hpi the cells
p panel) and anti-actin (bottom panel) antibodies. (B) Virus-free supernatants from
nd 24 h later the cells were lysed and the intracellular PKR and actin levels were
cells that were incubated with 1000 U/ml of chIFN for 24 h is shown in lanes 5 of A
culture medium of DF1 cells that had been transfected with the pGL3-P-chMx-luc
the luciferase activity of the extracts was determined with a luminometer. The
tion compared to that of unstimulated cells. The data are representative of three
urements for each experiment.
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both CEF and DF1 cells, since it is able to activate the expression of
those IFN-responsive genes expressing PKR and Mx.Fig. 3. IFN is induced at early infection times in ARV-infected CEF. CEF cell monolayer
harvested for RNA isolation, and virus-induced expression of chIFN-β was determined by
the error bars indicating the standard deviations of the mean. (B) The infected cells, as w
Western blot analysis with the antibodies indicated on the right. (C) The capacity to ac
determined as for C. The data are representative of three independent experiments, wi
Fig. 2. ARV-infected CEF cells express type-α and type-β IFNs. (A) The cultured medium
of CEF cells infected with 2 PFU/cell of ARV S1133 was supplemented at the onset of the
infection with antibodies against type-α IFN (lane 3), type-β IFN (lane 4), each at the
concentration of 2%, or with the two antibodies (lane 5) and incubated for 18 h. These
cells, as well as mock-infected nontreated cells (lane 1) and mock-infected cells primed
with IFN for 24 h (lane 6) were lysed and the extracts analyzed by Western blotting
with antibodies against the proteins indicated at the right of the ﬁgure. (B) Mock-
infected CEF cells, either untreated (lanes 1-3) or primed with IFN for 24 h (lane 7), as
well as CEF cells infected with 2 PFU/cell of ARV were incubated from the onset of the
infection with the concentrations of brefeldin A (BFA) indicated on top. The cells were
lysed at 18 hpi and the resulting extracts analyzed by Western blotting with antibodies
against the proteins indicated on the right. The sample in lane 7 was run on the same
gel, but two internal lanes were removed.ARV-infected CEF secrete type-α and type-β IFNs
To try to determine the type of chIFN (α or β) produced by ARV-
infected CEF cells, antibodies to chIFN-α and/or -β were added to
the culture medium of the infected cells and the intracellular
levels of PKR were monitored by Western blotting. The results
revealed that each of the two antibodies was capable of inhibiting
PKR induction, although maximal inhibition was only reached
when the two antibodies were simultaneously present in the
culture medium (Fig. 2A). These results not only indicate that ARV-
infected CEF cells secrete type-α and type-β chIFNs, but also
suggest that PKR is indirectly induced in these cells by the IFN
secreted to the cultured medium. To conﬁrm this suggestion we
analyzed the effect of brefeldin A (BFA) on PKR expression. BFA is a
macrolide antibiotic that has been shown to inhibit vesicle trans-
port to the cell surface, by causing the resorption of the Golgi
complex into the endoplasmic reticulum (Miller et al., 1992;
Nebenführ et al., 2002). It has been shown that 0.25 μg/ml of BFA
only caused a slight reduction of both intracellular muNS levels
and the production of infectious viral particles (Bodelón et al.,
2002), indicating that this antibiotic hardly affects ARV replication
and assembly. On the other hand, trypan blue staining of BFA-
treated CEF cells revealed that 95% of the cells were viable after
an incubation period of 18 h. The results shown in Fig. 2B revealed
that PKR expression is no longer induced when ARV-infected CEF
cells are incubated in the presence of 0.5 μg/ml of BFA (upper
panel, compare lanes 4 and 6), suggesting that PKR is not directly
induced by the viral infection, but by the IFN secreted by ARV-
infected CEF cells.
IFN induction in ARV-infected cells requires viral uncoating, but not
viral gene expression
Our next goal was to try to identify the stage of the ARV life cycle at
which IFN expression is induced. First of all, we determined the
relative production of chIFN-β mRNA in ARV-infected CEF at different
infection times. We analyzed the intrcellular levels of this mRNA
because it is encoded by a single gene, whereas there are multiples were infected with 2 PFU/cell of ARV for the hours indicated. (A) The cells were
real-time PCR. The data are representative of three independent experiments, with
ell as IFN-primed noninfected cells (lane 7) were lysed and the extracts subjected to
tivate the Mx promoter of virus-free supernatants from the cells shown in A was
th the error bars indicating the standard deviations of the mean.
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expression of the chIFN-βmRNAwas already observed at 3 hpi and its
intracellular levels increased signiﬁcantly at 6 hpi (Fig. 3A), indicating
that strong induction of the chIFN-β gene takes place at early infection
times. To conﬁrm this result we analyzed the intracellular PKR levels
and the capacity of the supernatants to activate the Mx promoter at
different infection times. Induction of PKR expression was already
detected at 6 hpi and intracellular PKR levels increased with time until
12 hpi, and then declined probably because of the damage caused by
the infection, as revealed by diminished actin levels (Fig. 3B). On the
other hand, the capacity of the supernatant from infected cells to
activate the Mx promoter was already detected at 3 hpi and steadily
increased until 12 hpi (Fig. 3C). These results indicate that IFN
expression is induced at an early stage of the ARV replication cycle. To
try to identify that stage we ﬁrst assessed whether intracellular virus
uncoating is required for IFN induction. For this, we examined the
effect of two lysosomotropic agents, ammonium chloride and chlor-
oquine, that have been previously shown to prevent intraendosomal
ARV uncoating by neutralizing vacuolar acidiﬁcation; as a con-
sequence virus protein synthesis and virus replication is blocked in
ARV-infected CEF incubated in the presence of any of these two agents
(Labrada et al., 2002). The results shown in Fig. 4A revealed that each
of the two inhibitors was very effective in preventing PKR induction
when added to cells at the onset of the infection (lanes 3 and 5), but
not when added 3 h later (lanes 4 and 6). Furthermore, the super-
natants from ARV-infected CEF that had been incubated with either of
the two inhibitors from the onset of the infection, but not when added
3 h later, were no longer able to activate the Mx promoter (Fig. 4B).
These results indicate that virus uncoating is required for IFN induc-
tion in ARV-infected cells.
To determine whether ARV gene expression is necessary for IFN
induction, we ﬁrst evaluated the effect of ribavirin, a nucleoside
analog that has been reported to block ARV transcription without
affecting the expression of cellular genes (Labrada et al., 2002).
Our ﬁnding that the production of the ARV nonstructural muNSFig. 4. Induction of IFN expression requires ARV uncoating. (A) CEF cells infected
with 2 PFU/cell of ARV (lanes 2–6) were treated with 100 μM chloroquine (lanes
3 and 4) or with 10 mM ammonium chloride (lanes 5 and 6), from the onset of the
infection (lanes 3 and 5) or from 3 hpi (lanes 4 and 6). At 18 hpi these cells, as well
as mock-infected nontreated cells (lane 1) and mock-infected cells primed with IFN
for 24 h (lane 7) were lysed and the extracts analyzed by Western blotting with
antibodies against the proteins indicated at the right of the ﬁgure. (B) The capacity
to activate the Mx promoter of virus-free supernatants from the cells shown in A
was determined as for C. The data are representative of three independent
experiments, with the error bars indicating the standard deviations of the mean.protein is blocked when ARV-infected cells are incubated in the
presence of 100 μΜ ribavirin indicates that the nucleoside analog
is effective in blocking ARV gene expression (compare lanes 3 and
4 in the middle panel of Fig. 5A). However, ribavirin failed to
inhibit PKR expression in ARV-infected CEF (compare lanes 3 and
4 in the upper panel of Fig. 5A), and the supernatant from
ribavirin-treated ARV-infected cells was still able to activate the
Mx promoter (Fig. 5B). Since ribavirin has been shown to induce
the expression of a subset of the IFN-responsive genes in unin-
fected cells (Thomas et al., 2011), we followed an alternative
approach to examine whether ARV gene expression is required for
IFN induction. For this, we evaluated the capacity of ultraviolet-
inactivated ARV virions to induce IFN expression. As previously
shown (Labrada et al., 2002), treatment of puriﬁed reovirions with
ultraviolet light (UV) completely blocked ARV gene expression, as
revealed by the absence of muNS production (compare lanes 2 and
3 in the middle panel of Fig. 5C), and also caused inactivation of
virus infectivity as determined by plaque assay (not shown). In
contrast, PKR expression was still induced when CEF cells were
incubated with UV-treated virions (lane 3 in the upper panel of
Fig. 5C), and the supernatant from these cells was still able to
activate the Mx promoter (Fig. 5D). Taken together, these results
indicate that viral gene expression is not required for IFN induc-
tion in ARV-infected CEF.
Apoptosis activation and IFN induction are unrelated events
The results shown so far indicate that IFN is induced in ARV-
infected CEF at a stage of the virus life cycle subsequent to virus
uncoating, but prior to virus gene expression. Since a similar situation
has been previously reported for apoptosis induction in ARV-infected
cells (Labrada et al., 2002), we next examined whether apoptosis is
required for IFN induction in ARV-infected cells. For this, we examined
the effect of the pancaspase inhibitor Q-VD-OPh, which has been
shown to be very effective in preventing the activation of effector
caspases and the conversion of muNS into muNSC in ARV-infected CEF
(Rodríguez-Grille et al., 2014). The results revealed that, while the
caspase inhibitor was very effective in preventing both the activation of
effector caspases (Fig. 6A) and the conversion of muNS into muNSC
(middle panel of Fig. 5B, compare lanes 3 and 4), Q-VD-OPhwas unable
to inhibit PKR expression by ARV-infected cells (upper panel of Fig. 6B,
compare lanes 3 and 4). These results suggest that IFN induction in
ARV-infected cells is triggered by a caspase-independent mechanism.Discussion
In this study we have analyzed the capacity of three different
viruses to induce the expression of IFN when infecting CEF cells.
The results revealed that only the infection with ARV, but not with
VSV or VV, induces the expression and secretion of chIFN, which in
turn indicates that signaling pathways mediating IFN gene
expression are nonfunctional in VSV- or VV-infected avian cells. In
the case of VV, it has been reported that the genome of this virus
expresses a broad range of immune modulators, and some of them
have been shown to block IFN expression by inhibiting PRR sig-
naling pathways (Perdiguero and Esteban, 2009; Smith et al., 2013;
Waibler et al., 2009). Our ﬁnding that IFN is not expressed by VV-
infected CEF cells suggests that some of these viral modulators are
active in avian cells. On the other hand, the absence of IFN
induction that we have observed in VSV-infected CEF might be
attributed to the capacity of the viral M protein to prevent IFN
expression. This protein has been reported to block IFN induction
in infected mammal cells by inhibiting nuclear transcription and
the nucleocytoplasmic transport of cellular mRNAs (Ahmed et al.,
2003; Faul et al., 2009; Ferran and Lucas-Lenard, 1997). Our
Fig. 5. ARV gene expression is not required for IFN induction. (A) Mock-infected CEF (lanes 1 and 2) and ARV-infected CEF (lanes 3 and 4) were incubated from the onset of
the infection with 100 μM ribavirin (lanes 2 and 4). At 18 hpi these cells, as well as IFN-primed uninfected cells (lane 5) were lysed and the extracts subjected to Western blot
analysis with antibodies against the proteins indicated on the right. (B) The capacity to activate the Mx promoter of virus-free supernatants from the cells shown in A was
determined as for C. The data are representative of three independent experiments, with the error bars indicating the standard deviations of the mean. (C) Monolayers of CEF
were mock infected (lane 1) or infected with puriﬁed ARV virions that had been inactivated (lane 3) or not (lane 2) by UV light treatment. At 18 hpi the cells were lysed and
the extracts analyzed byWestern blotting with antibodies against the proteins indicated on the right. (D) The capacity to activate the Mx promoter of virus-free supernatants
from the cells shown in C was determined as for C. The data are representative of three independent experiments, with the error bars indicating the standard deviations of
the mean.
Fig. 6. Effect of Q-VD-OPh on caspase activity and IFN induction. (A) CEF monolayers were mock-infected (U) or infected with 2 PFU/cell of ARV in the absence (lanes ) or
presence (lanes þ) of 10 μM Q-VD-OPh. At 18 hpi caspase activity was determined with the Caspase-Glo 3/7 Assay kit (Promega) following the manufacturer's instructions,
and the results were expressed as arbitrary RLU units. Each value is the mean of three independent experiments. (B) A replica of the cells shown in Awere lysed at 18 hpi and
the cell extracts were subjected to Western blot analysis with antibodies against the proteins indicated on the right.
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the nucleus of CEF cells, together with the fact that cellular protein
synthesis is drastically reduced in VSV-infected CEF (Martinez-
Costas et al., 2000), suggests that the M protein also plays a key
role in preventing IFN induction in VSV-infected avian cells. Other
viruses, like inﬂuenza viruses A and B, Thogoto virus, herpes
simplex virus type 1, human immunodeﬁciency virus, and Epstein-
Barr virus, have also been reported to use mechanisms for blocking
IFN induction in infected cells (Alcamí and Koszinowski, 2000;
Weber and Haller, 2007).
The results of this study revealed that type-α and type-β IFNs
are both produced by ARV-infected CEF cells, a situation similar to
that reported for CEF cells infected with MVA or with an NS1-
defective inﬂuenza virus. In contrast, only IFN-α was detected
during the infection of CEF with Newcastle disease virus, Rift
valley fever virus, or Thogoto virus (Schwarz et al., 2004). Addi-
tional experiments were performed to assess the stage of the ARV
life cycle at which the expression of IFN is induced. Our ﬁndings
revealed that IFN expression is induced at an early stage of the
virus replication cycle. This suggestion is supported by the factthat IFN induction does not require expression of the ARV genes,
since it takes place when the cells are incubated with UV-treated
virus or when ARV-infected cells are incubated in the presence of
ribavirin. In both cases IFN expression, but not the expression of
ARV genes, was detected. The nondependence of IFN induction on
viral gene expression indicates that IFN is induced by parental viral
particles at a stage prior to viral transcription and suggests that
viral mRNAs and viral nonstructural proteins should not act as IFN
inducers. However, the possibility still exists that abortive tran-
scripts produced in cells incubated with UV-treated reovirions or
in ribavirin-treated ARV-infected cells could act as IFN inducers.
Thus, it has been reported that UV-treatment of mammalian reo-
virions generates particles that are able to synthesize small
amounts of incomplete viral transcripts (Henderson and Joklik,
1978) and, if the same holds true for the treatment of avian reo-
virions, these transcripts could be the trigger for IFN induction. On
the other hand, ribavirin has been shown to block transcription
elongation, but not the initiation of RNA synthesis (Rankin et al.,
1989), so abortive reoviral transcripts generated in ribavirin-
treated cells might act as IFN inducers.
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to ARV-infected cells at the onset of the infection, but not when
added 3 h later, indicates both that intraendosomal virus uncoat-
ing is necessary to trigger IFN expression and that the expression
of IFN is induced at a post-attachment step. Our ﬁndings that IFN
induction requires virus uncoating but not viral gene expression
suggests that the viral PAMPs detected by the cellular PRRs should
be ARV products generated or exposed upon intraendosomal
uncoating, and not by intact viral particles. These products might
be core proteins or viral nucleic acids, like the adenine-rich oli-
gonucleotides or the genome segments present in ARV particles.
Since reovirus cores must cross the endosomal membrane to reach
the cytoplasm for expressing the viral genes, cellular PRRs for the
detection of ARV infection could be endosomal-associated PRRs,
such as toll-like receptors, or cytoplasmic PRRs, such as RIG-
helicases. Additional studies are needed to identify both the viral
trigger and the cellular sensor that are responsible for IFN induc-
tion in ARV-infected avian cells.
Data presented in this report indicates that PKR expression is
induced in ARV-infected CEF cells, but not in VSV- or VV-infected
cells, and that the expression of this kinase is indirectly induced by
the IFN secreted by ARV-infected cells. On the other hand, in a
previous report we have presented evidences that the ARV protein
sigmaA exerts an anti-IFN function by preventing PKR activation
(González-López et al., 2003). Although the role that PKR plays on
ARV replication is the subject of another study (manuscript in
preparation), we can speculate that PKR expression might beneﬁt
ARV replication by promoting the selective inhibition of cellular
protein synthesis observed in ARV-infected CEF (Martinez-Costas
et al., 2000; Labrada et al., 2002). Thus, as has been reported for
mammalian reovirus protein sigma3 (Schmechel, et al., 1997),
localization of sigmaA in and around perinuclear viral factories
would prevent PKR activation and allow the translation of viral
mRNAs, while PKR would be activated and the synthesis of cellular
proteins blocked elsewhere in the cytosol. Alternatively, the sig-
maA protein expressed in ARV-infected cells might partially inhi-
bit PKR activation, leading to intracellular levels of phosphorylated
eIF-2α that would block the translation of cellular mRNAs, but not
of their viral counterparts. A pro-viral effect of PKR expression has
similarly been reported for the replication of mammalian reo-
viruses (Smith et al., 2005).Materials and methods
Cells and viruses
Primary cultures of CEF cells were prepared from 9- to 10-day-
old embryos from speciﬁc pathogenic free chickens, and grown as
monolayers in medium 199 supplemented with 10% tryptose
phosphate broth and 5% calf serum. Chicken ﬁbroblast DF-1 cells
and baby hamster kidney BHK-21 cells were grown as monolayers
in Dulbecco's Modiﬁed Eagle's medium (D-MEM, Invitrogen).
Vaccinia virus (VV; Western Reserve strain) and vesicular stoma-
titis virus (VSV; Indiana serotype) were grown on BHK-21 cell
monolayers. Avian reovirus (ARV) strain S1133 was grown on
semiconﬂuent monolayers of CEF cells, and puriﬁed by CsCl-
gradient centrifugation as previously described (Grande and
Benavente, 2000), except that Freon was replaced by Vertrel-XF
(Mendez et al., 2000).
For ultraviolet inactivation, puriﬁed ARV virions kept on ice
were exposed to a 254 nm UV light for 15 min, as described by
Tyler et al. (1995). UV-inactivated virus was devoid of infectious
virus particles as determined by plaque assay.Antibodies, plasmids and reagents
Anti-actin antibody (rabbit polyclonal, sc-1616R) was pur-
chased from Santa Cruz Biotechnology and HRP-conjugated goat
anti-rabbit IgG from Sigma. Rabbit polyclonal anti-muNS protein
was raised in our laboratory (Tourís-Otero et al., 2004). Rabbit
polyclonal anti-chicken PKR antibody was generated by Bio-
Synthesis, using as immunogen a KLH-conjugated synthetic pep-
tide comprising amino acids 527–550 of chicken PKR. Rabbit
antibodies against chicken IFNs α and β were a kind gift from Dr.
Peter Staeheli (Sick et al., 1996).
The reporter plasmid that contains the luciferase gen under the
control of the chicken Mx promoter (pGL3-P-chMx-Luc) was a gift
from Dr. Nicolas Ruggli (Liniger et al., 2012). Ammonium chloride,
chloroquine, ribavirin and brefeldin A were purchased from Sigma,
the pancaspase inhibitor Q-VD-OPh was from Calbiochem, lipo-
fectamine from Invitrogen and the recombinant chicken IFN alpha
from AbD-Serotec (#PAP004).
Western blotting
Cells were washed twice with PBS, lysed in Laemmli sample
buffer (Laemmli, 1970) and boiled for 5 min. The resulting extracts
were then subjected to SDS-PAGE electrophoresis, and the gel
proteins transferred to PVDF membranes (Immobilon-P, Millipore)
for 1 h at 100 V using a trans-blot electrophoretic transfer unit
(Bio-Rad). Membranes were blocked for 1 h with PBS containing
0.05% Tween-20 and 4% non-fat dry milk, and incubated for 2 h
with the primary antibodies diluted in blocking solution. After
several washes, membranes were incubated for 45 min with HRP-
conjugated goat anti-rabbit IgG and visualized by chemilumines-
cence (Immobilon Western Chemiluminescent HRP Substrate,
Millipore).
Preparation of virus-free supernatants and Mx-promoter activation
assays
The virus was removed from the supernatants by perchloric
acid (PCA) precipitation (Sekellick and Marcus, 1986). Brieﬂy, fetal
bovine serum in the culture medium was raised to 6% before
adding 0.15 volumes of cold PCA. Samples were incubated for 24 h
in a cold room and the precipitate removed by centrifugation at
2000 rpm 10 min. PCA in the supernatant was neutralized with
KOH, and the pH adjusted to 6.8. The precipitate that forms after
neutralization was removed by centrifugation, and the IFN-
containing supernatant was ﬁlter-sterilized through a 0.22-μM
Millex ﬁlter (Millipore) before further use. Alternatively, super-
natants from monolayers of infected cells were centrifugated at
4 °C for 5 min at 2000 rpm to remove cellular debris, and the
resulting supernatants were incubated at 65 °C for 30 min to
inactivate the virus (Liniger et al., 2012).
To determine the activation of the chicken Mx promoter,
monolayers of DF-1 cells were transfected with the pGL3-P-chMx-
luc plasmid and incubated 24 h later with either 50 μl of virus-free
supernatants or 100 U/ml of IFN for 24 h. The cells were then
harvested and lysed in CCLR buffer (Promega). The luciferase
activity of the extracts was determined with a Luminoskan Ascent
luminometer.
Quantitative real-time PCR of chIFN-β mRNA levels in ARV-infected
CEF cells
CEF cell monolayers were infected with 2 PFU/cell of ARV
S1133, and at 0, 3 and 6 hpi cell samples were collected and their
RNA was extracted using Trizol (Life Technologies). The RNA
samples were treated with DNase RQ I (Promega) for 35 min at
I. Lostalé-Seijo et al. / Virology 487 (2016) 104–11111037 °C and the enzyme was subsequently inactivated by incubation
at at 65 °C for 10 min in the presence of DNase Stop Solution
(Promega). Total RNA was reverse transcribed into cDNA using the
iScriptTM cDNA Synthesis kit (Bio-Rad) according to the manu-
facturer's instructions and the following incubation times: 25 °C
for 5 min, 42 °C for 40 min and 85 °C for 5 min. Then the exonu-
clease activity of the reverse transcriptase was heat-inactivated at
95 °C for 5 min. The cDNA was diluted 10 times in water, aliquoted
and stored at 80 °C. For quantitative PCR ampliﬁcation the fol-
lowing primers were used.
qPCR reactions of 10 ml contained 5 ml of IQ SYBR Green Super
Mix (Bio-Rad), 2.5 ml of cDNA and 300 nM of each primer. For the
detection of chicken IFN-β mRNA (NM_001024836.1), the forward
primer was 50CAACACCTCTTCAACATGCTTAG 30 and the reverse
primer was 50TGCTCAAGGTGATGGATGTAAT 30. These primers
were validated using serial dilutions of the pcDNA-I-IFNb plasmid
(94.8% efﬁciency at a Tm of 63.4 °C). An initial denaturalization
step of 3 min at 95 °C was followed by 40 cycles (10 s at 95 °C, 30 s
at 63.4 °C and 10 s at 72 °C) using a C1000 Touch thermocycler
with a CFX96 optical module (Bio-Rad). An end-point single
ﬂuorescence was measured after each extension step. After the
ampliﬁcation we carried out an analysis of the dissociation curve
from 65 to 95 °C by raising the temperature 0.5 °C every 5 s, to
verify the speciﬁcity of the obtained products. The results were
analyzed and processed with the CFX Manager software (Bio-Rad).
The relative amount of the mRNA was normalized to the internal
β-actin control, and chicken β-actin gene expression was detected
using previously described primers (Li et al., 2007).Acknowledgments
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